1. Home
  2. BORR vs SVRA Comparison

BORR vs SVRA Comparison

Compare BORR & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

N/A

Current Price

$3.44

Market Cap

995.8M

Sector

Energy

ML Signal

N/A

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$4.79

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BORR
SVRA
Founded
2016
2007
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
995.8M
1.1B
IPO Year
2017
2009

Fundamental Metrics

Financial Performance
Metric
BORR
SVRA
Price
$3.44
$4.79
Analyst Decision
Buy
Strong Buy
Analyst Count
7
9
Target Price
$4.93
★ $11.06
AVG Volume (30 Days)
★ 8.5M
2.9M
Earning Date
11-18-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.14
$4,204.68
P/E Ratio
$20.64
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.89
$4.13
52 Week High
$6.66
$7.01

Technical Indicators

Market Signals
Indicator
BORR
SVRA
Relative Strength Index (RSI) 43.43 50.47
Support Level $3.10 $4.73
Resistance Level $4.64 $5.40
Average True Range (ATR) 0.20 0.31
MACD -0.00 -0.00
Stochastic Oscillator 31.90 52.84

Price Performance

Historical Comparison
BORR
SVRA

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: